Ro­bot­ic pill mak­er Rani paus­es pro­grams, cuts head­count to ex­tend cash run­way through 2025

Rani Ther­a­peu­tics is sus­pend­ing two pro­grams and ax­ing a third pro­gram along­side a quar­ter of its work­force as part of a strate­gic reshuf­fling so that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.